Literature DB >> 12228274

Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses.

Chao Huang1, Shu-Hua Nong, Michael K Mansour, Charles A Specht, Stuart M Levitz.   

Abstract

Although T-cell responses are known to be critical for effective host defenses against the fungal pathogen Cryptococcus neoformans, the antigens that stimulate protective responses are poorly characterized but are thought to be comprised, at least in part, of mannoproteins. Recently, we created a panel of murine CD4(+)-T-cell hybridomas that react with C. neoformans antigens. A mannoprotein antigen, MP98, that stimulated one of the hybridomas was purified, and the gene encoding MP98 was cloned. In the present study, the cryptococcal antigen, MP88, that stimulated a second T-cell hybridoma, X5A3, to secrete interleukin-2 was characterized. MP88 was purified from supernatants of glass bead-disrupted C. neoformans by anion-exchange and hydrophobic interaction chromatography. A single band with an apparent molecular mass of 88 kDa was resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and subjected to partial internal amino acid sequencing. The gene encoding MP88 was cloned and sequenced. MP88 features a C-terminal serine/threonine-rich region, which presumably serves as a site for extensive O glycosylation, followed by a putative glycosylphosphatidylinositol anchor site. A search of C. neoformans genomic databases revealed that MP88 shares this feature with at least 11 other genes, including MP98. The mannoprotein nature of MP88 was established based upon the capacity of (i) the mannoprotein fraction of C. neoformans supernatants to stimulate X5A3 and (ii) mannosylated ligands to competitively inhibit this stimulation. Thus, a second cryptococcal mannoprotein has been identified which stimulates T-cell responses and is a vaccine candidate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228274      PMCID: PMC128329          DOI: 10.1128/IAI.70.10.5485-5493.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection.

Authors:  J F Hoy; J W Murphy; G G Miller
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

2.  Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors.

Authors:  Michael K Mansour; Larry S Schlesinger; Stuart M Levitz
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

3.  Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans.

Authors:  J W Murphy; F Schafer; A Casadevall; A Adesina
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Differences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformans.

Authors:  Kasie L Nichols; Sean K Bauman; Fredda B Schafer; Juneann W Murphy
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans.

Authors:  S M Levitz; S Nong ; M K Mansour; C Huang; C A Specht
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

6.  Identification and cloning of a cryptococcal deacetylase that produces protective immune responses.

Authors:  Carmelo Biondo; Concetta Beninati; Demetrio Delfino; Marco Oggioni; Giuseppe Mancuso; Angelina Midiri; Mauro Bombaci; Giuseppe Tomaselli; Giuseppe Teti
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

7.  Cloning, characterization and expression of complete coding sequences of three IgE binding Malassezia furfur allergens, Mal f 7, Mal f 8 and Mal f 9.

Authors:  O Rasool; A Zargari; J Almqvist; H Eshaghi; P Whitley; A Scheynius
Journal:  Eur J Biochem       Date:  2000-07

8.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

9.  Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens.

Authors:  J W Murphy; R L Mosley; R Cherniak; G H Reyes; T R Kozel; E Reiss
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

10.  Influence of cryptococcal antigens on cell-mediated immunity.

Authors:  J W Murphy
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug
View more
  39 in total

Review 1.  A yeast under cover: the capsule of Cryptococcus neoformans.

Authors:  Indrani Bose; Amy J Reese; Jeramia J Ory; Guilhem Janbon; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2003-08

2.  Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.

Authors:  Neena Jain; Li Li; Ye-Ping Hsueh; Abraham Guerrero; Joseph Heitman; David L Goldman; Bettina C Fries
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

3.  Autocrine IL-10 Signaling Promotes Dendritic Cell Type-2 Activation and Persistence of Murine Cryptococcal Lung Infection.

Authors:  Seagal Teitz-Tennenbaum; Steven P Viglianti; Jonathan A Roussey; Stuart M Levitz; Michal A Olszewski; John J Osterholzer
Journal:  J Immunol       Date:  2018-08-10       Impact factor: 5.422

4.  Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens.

Authors:  Maureen M Hester; Chrono K Lee; Ambily Abraham; Payam Khoshkenar; Gary R Ostroff; Stuart M Levitz; Charles A Specht
Journal:  Vaccine       Date:  2019-11-04       Impact factor: 3.641

Review 5.  Exploiting fungal cell wall components in vaccines.

Authors:  Stuart M Levitz; Haibin Huang; Gary R Ostroff; Charles A Specht
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

6.  Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans.

Authors:  Carmelo Biondo; Concetta Beninati; Mauro Bombaci; Luciano Messina; Giuseppe Mancuso; Angelina Midiri; Roberta Galbo; Giuseppe Teti
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

7.  Cryptococcus neoformans gene expression during experimental cryptococcal meningitis.

Authors:  B R Steen; S Zuyderduyn; D L Toffaletti; M Marra; S J M Jones; J R Perfect; J Kronstad
Journal:  Eukaryot Cell       Date:  2003-12

8.  Protective efficacy of antigenic fractions in mouse models of cryptococcosis.

Authors:  Michael K Mansour; Lauren E Yauch; James B Rottman; Stuart M Levitz
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule.

Authors:  Teresa R O'Meara; Diana Norton; Michael S Price; Christie Hay; Meredith F Clements; Connie B Nichols; J Andrew Alspaugh
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

10.  Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Sailatha Ravi; Sandra Macias; Mattie L Young; Michal A Olszewski; Chad Steele; Floyd L Wormley
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.